{"canonical":"https://abierto.us/vendors/novomedix-llc-xqymhkgdmu75","key":"XQYMHKGDMU75","name":"NOVOMEDIX LLC","uei":"XQYMHKGDMU75","city":"SAN DIEGO","state":"CA","awards":2,"obligated":"2977013.00","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"4C2X1","parent_name":"NOVOMEDIX LLC","also_known_as":[],"country":"USA","actions":3,"first_action":"2024-04-12","last_action":"2025-09-30","breakdowns":{"naics":[{"key":"541715","name":null,"awards":2,"obligated":"2977013.00"}],"places":[{"key":"CA","name":null,"awards":2,"obligated":"2977013.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"2977013.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":2,"obligated":"2977013.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"2977013.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":2,"obligated":"2977013.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":2,"obligated":"2977013.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N91025C00051_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91025C00051_7529_-NONE-_-NONE-/","piid":"75N91025C00051","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"XQYMHKGDMU75","recipient_name":"NOVOMEDIX LLC","recipient_uei":"XQYMHKGDMU75","recipient_cage":"4C2X1","recipient_city":"SAN DIEGO","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2025-09-15","last_action_date":"2025-09-30","actions":2,"obligated":"2977013.00","current_total_value":"2977013.00","potential_total_value":"2977013.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":16,"description":"SBIR PHASE II - ENHANCED OVERALL SURVIVAL IN HIGH-RISK PEDIATRIC SOLID TUMORS USING A NOVEL ORAL SMALL MOLECULE","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N91022C00001_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91022C00001_7529_-NONE-_-NONE-/","piid":"75N91022C00001","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"XQYMHKGDMU75","recipient_name":"NOVOMEDIX LLC","recipient_uei":"XQYMHKGDMU75","recipient_cage":"4C2X1","recipient_city":"SAN DIEGO","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-04-12","last_action_date":"2024-04-12","actions":1,"obligated":"0","current_total_value":"355000.00","potential_total_value":"355000.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":47,"description":"SBIR CONCEPT AWARD TO NOVOMEDIX- NOVEL SMALL MOLECULES FOR THE TREATMENT OF RHABDOMYOSARCOMA","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}